Skip to main content

Refine your results

Filters
Search
Include spaces in matter number if applicable. Ex.: 182 3125
Date
Displaying 23621 - 23640 of 45459
Cases and Proceedings

Actavis Group hf. and Abrika Pharmaceuticals, Inc., In the Matter of

The Commission prevented a merger-to-monopoly in the sale of generic isradipine capsules by challenging the proposed $235 million purchase of Abrika Pharmaceuticals, Inc., by the Actavis Group, an international generic pharmaceuticals company. To maintain competition in the market for this important generic drug, used to lower blood pressure and to treat hypertension, ischemia, and depression, the consent order requires the divestiture of all rights and assets necessary to produce, market, and sell generic isradipine to Cobalt Laboratories, Inc.
Type of Action
Administrative
Last Updated
FTC Matter/File Number
0710063
Cases and Proceedings

Dondero, James D. c/o Highland Capital Management, LP, United States of America (for the FTC)

In 2007, the Commission requested that the Department of Justice file a complaint seeking civil penalties against James D. Dondero for violating the filing requirements of the Hart-Scott-Rodino Pre-Merger Notification Act. A stipulation and proposed final judgment was also filed requiring Dondero, parent of Highland Capital Management, L.P., a hedge fund, to pay $250,000 to settle the charges. According to the Commission, Highland failed to file the appropriate premerger documents in 2003 when it acquired shares of Neighborcare, Inc, then known as Genesis Health Ventures, bringing its holdings above the $50 million filing threshold. Upon realizing the error, a corrective filing was made, and Highland outlined steps to avoid future violations. However, in 2005, Highland reported another such violation involving shares of Motient Corporation.

Type of Action
Federal
Last Updated
FTC Matter/File Number
0510184
Displaying 23621 - 23640 of 45459
Return to top